Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Reply: To PMID 23265344.

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC.

J Am Coll Cardiol. 2013 Jul 2;62(1):84-5. doi: 10.1016/j.jacc.2013.03.024. Epub 2013 Apr 3. No abstract available.

2.

Reply: To PMID 23265344.

Macchia A, Nul D, Grancelli H, Varini S, Mariani J, Doval HC.

J Am Coll Cardiol. 2013 Apr 9;61(14):1552-3. doi: 10.1016/j.jacc.2013.01.033. No abstract available.

3.

Omega-3 fatty acids and prevention of atrial fibrillation.

Song ZZ.

J Am Coll Cardiol. 2013 Jul 2;62(1):84. doi: 10.1016/j.jacc.2013.02.067. Epub 2013 Apr 3. No abstract available.

4.

Are omega-3 fatty acids ineffective for preventing atrial fibrillation recurrence?

Guo X, Dong J, Du X, Ma C.

J Am Coll Cardiol. 2013 Apr 9;61(14):1552. doi: 10.1016/j.jacc.2013.01.032. No abstract available.

5.

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC; GESICA Investigators.

J Am Coll Cardiol. 2013 Jan 29;61(4):463-8. doi: 10.1016/j.jacc.2012.11.021. Epub 2012 Dec 19.

6.

Reply: To PMID 23265334.

Suman-Horduna I, Roy D, Talajic M, Khairy P.

J Am Coll Cardiol. 2013 May 28;61(21):2197. doi: 10.1016/j.jacc.2013.02.042. Epub 2013 Mar 26. No abstract available.

7.

N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.

Ozaydın M, Erdoğan D, Tayyar S, Uysal BA, Doğan A, Içli A, Ozkan E, Varol E, Türker Y, Arslan A.

Anadolu Kardiyol Derg. 2011 Jun;11(4):305-9. doi: 10.5152/akd.2011.080. Epub 2011 May 5.

8.

Failure of omega-3 fatty acids in atrial fibrillation? No deficiency of highly unsaturated fatty acids in the absence of heart failure.

Rupp H, Rupp TP, Alter P, Maisch B.

Europace. 2011 Sep;13(9):1357; author reply 1357-8. doi: 10.1093/europace/eur149. Epub 2011 May 11. No abstract available.

PMID:
21561901
9.

[Class-1C drugs for oral loading in the cardioversion of paroxysmal atrial fibrillation].

Capucci A, Rosi A, Villani GQ, Aschieri D, Piepoli M.

G Ital Cardiol. 1998 Dec;28(12):1422-30. Review. Italian. No abstract available.

PMID:
9887399
10.

A short course of oral amiodarone improves sinus rhythm maintenance post-cardioversion for atrial fibrillation.

Boos C, Ritzema J, More RS.

Heart. 2004 Sep;90(9):1063-4. No abstract available.

11.

Cardioversion of atrial fibrillation with ibutilide in an orthotopic heart transplant patient.

Kaufman LJ, Kofalvi AE, Hong RA, Moreno-Cabral CE, Low LL.

J Heart Lung Transplant. 1999 Oct;18(10):1018-20. Review. No abstract available.

PMID:
10561113
12.

n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.

Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.

Europace. 2011 Feb;13(2):174-81. doi: 10.1093/europace/euq386. Epub 2010 Nov 8.

PMID:
21059740
13.

Omega-3 fatty acids and cardiac arrhythmias.

Rix TA, Christensen JH, Schmidt EB.

Curr Opin Clin Nutr Metab Care. 2013 Mar;16(2):168-73. doi: 10.1097/MCO.0b013e32835bf39b. Review.

PMID:
23196815
14.

When palpitations worsen.

Indik JH.

Am J Med. 2010 Jun;123(6):517-9. doi: 10.1016/j.amjmed.2010.01.012. No abstract available.

PMID:
20569756
15.

[Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].

[No authors listed]

MMW Fortschr Med. 2006 Jun 8;148(23):58-9. German. No abstract available.

PMID:
16826742
16.

Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure.

Suman-Horduna I, Roy D, Frasure-Smith N, Talajic M, Lespérance F, Blondeau L, Dorian P, Khairy P; AF-CHF Trial Investigators.

J Am Coll Cardiol. 2013 Jan 29;61(4):455-60. doi: 10.1016/j.jacc.2012.10.031. Epub 2012 Dec 19.

17.

Using omega-3 fatty acids to treat persistent atrial fibrillation: time to fish or cut bait?

Sullivan RM, Olshansky B.

Heart Rhythm. 2012 Apr;9(4):492-3. doi: 10.1016/j.hrthm.2011.12.003. Epub 2011 Dec 6. No abstract available.

PMID:
22155322
18.

Treatment targets in atrial fibrillation: "Is feeling better good enough?".

Kim MH.

J Am Coll Cardiol. 2013 Jan 29;61(4):461-2. doi: 10.1016/j.jacc.2012.08.1027. Epub 2012 Dec 19. No abstract available.

19.

Improving quality of life and functional capacity in atrial fibrillation and congestive heart failure.

Shelton RJ, Cleland JG.

J Am Coll Cardiol. 2013 May 28;61(21):2196-7. doi: 10.1016/j.jacc.2013.01.083. Epub 2013 Mar 26. No abstract available.

20.

[Atrial remodeling and anti-remodeling therapy in atrial fibrillation].

Neumann T, Hölschermann H.

Dtsch Med Wochenschr. 2006 Apr 21;131(16):884-7. German. No abstract available.

PMID:
16625482

Supplemental Content

Support Center